Silva Luisa, Qureshi Nadeem, Abdul-Hamid Hasidah, Weng Stephen, Kai Joe, Leonardi-Bee Jo
Primary Care Stratified Medicine (PRISM) Group, NIHR School of Primary Care Research, University of Nottingham, Nottingham NG7 2RD, UK.
Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh 47000, Malaysia.
J Pers Med. 2021 Apr 15;11(4):302. doi: 10.3390/jpm11040302.
Familial hypercholesterolaemia (FH) is a common inherited cause of premature cardiovascular disease, but the majority of patients remain undiagnosed. The aim of this systematic review was to assess the effectiveness of interventions to systematically identify FH in primary care. No randomised, controlled studies were identified; however, three non-randomised intervention studies were eligible for inclusion. All three studies systematically identified FH using reminders (on-screen prompts) in electronic health records. There was insufficient evidence that providing comments on laboratory test results increased the identification of FH using the Dutch Lipid Clinic Network (DLCN) criteria. Similarly, using prompts combined with postal invitation demonstrated no significant increase in definite FH identification using Simon-Broome (SB) criteria; however, the identification of possible FH increased by 25.4% (CI 17.75 to 33.97%). Using on-screen prompts alone demonstrated a small increase of 0.05% (95% CI 0.03 to 0.07%) in identifying definite FH using SB criteria; however, when the intervention was combined with an outreach FH nurse assessment, the result was no significant increase in FH identification using a combination of SB and DLCN criteria. None of the included studies reported adverse effects associated with the interventions. Currently, there is insufficient evidence to determine which is the most effective method of systematically identifying FH in non-specialist settings.
家族性高胆固醇血症(FH)是早发性心血管疾病常见的遗传病因,但大多数患者仍未得到诊断。本系统评价的目的是评估在初级保健中系统识别FH的干预措施的有效性。未检索到随机对照研究;然而,三项非随机干预研究符合纳入标准。所有三项研究均通过电子健康记录中的提醒(屏幕提示)系统识别FH。没有足够的证据表明,根据荷兰脂质诊所网络(DLCN)标准,对实验室检测结果进行注释能增加FH的识别率。同样,使用提示并结合邮寄邀请函,根据西蒙-布鲁姆(SB)标准,确诊FH的识别率没有显著提高;然而,可能FH的识别率提高了25.4%(95%置信区间为17.75至33.97%)。仅使用屏幕提示,根据SB标准,确诊FH的识别率略有提高,为0.05%(95%置信区间为0.03至0.07%);然而,当干预措施与FH外展护士评估相结合时,根据SB和DLCN标准联合使用,FH的识别率没有显著提高。纳入的研究均未报告与干预措施相关的不良反应。目前,没有足够的证据来确定在非专科环境中系统识别FH的最有效方法。